Sort
17,288 grants matching “multiple sclerosis”
Modulating microglial phenotype to prevent SCI-induced central neuropathic pain
$0Mousumi Ghosh · Miami Va Health Care System · I01 · FY2017 · VA
Promotion of Functional Recovery From Demylinating Disease
$0George Henry De Vries · Edward Hines Jr Va Hospital · I01 · FY2009 · VA
Assistive Device Training for Functional Mobility and Connectivity in MS
$0Michelle Hannah Cameron · Portland Va Medical Center · I21 · FY2015 · VA
Investigating a Model for PM-Induced Exacerbation of Autoimmunity
$0Joshua D Mezrich · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2021 · VA
Thymosin Beta 4: A Novel Biologic Therapy for Post-traumatic Osteoarthritis
$0Ann Duskin Chauffe · Veterans Health Administration · IK1 · FY2014 · VA
Innovative multimodal and attention training to improve emotion communication in Veterans with TBI and PTSD
$0Julia Kay Waid-Ebbs · Veterans Health Administration · I21 · FY2023 · VA
Reprogrammed cell therapy for white matter restoration in aged brain ischemia
$0Guodong Cao · Veterans Health Administration · I01 · FY2019 · VA
Evaluation of a Spasticity Management Program for People with Multiple Sclerosis
$0Lucinda L Hugos · Portland Va Medical Center · I01 · FY2022 · VA
Dendritic Cell Regulation by Sphingosine-1-phosphate in Inflammatory Bowel Disease
$0Jesus Rivera-Nieves · Va San Diego Healthcare System · I01 · FY2019 · VA
Molecular Mimicry in Immune Mediated Neurologic Disease
$0Michael Levin · Memphis Va Medical Center · I01 · FY2014 · VA
Comprehensive Fall Prevention and Detection in MS
$0Michelle Hannah Cameron · Portland Va Medical Center · I01 · FY2019 · VA
ShEEP Request for Simoa SR-Plex Digital Immunoassay Platform (HD-1 Analyzer)
$0Bingren Hu · Baltimore Va Medical Center · IS1 · FY2018 · VA
Next-Generation High-Density Wireless Peripheral Nerve Stimulator
$0Douglas B. Shire · Louis Stokes Cleveland Va Medical Center · I01 · FY2018 · VA
Noninvasive cervical electrical stimulation for ALS: Mechanistic and safety study
$0Noam Y. Harel · James J Peters Va Medical Center · I21 · FY2019 · VA
Immunomodulation and Neuroprotection in Multiple Sclerosis
$0Inderjit Singh · Ralph H Johnson Va Medical Center · I01 · FY2021 · VA
BLR&D Research Career Scientist Award Application
$0Gary Cecchini · Veterans Affairs Med Ctr San Francisco · IK6 · FY2021 · VA
AVONEX (IFN B1A) IN SUBJECTS AT HIGH RISK FOR DEVELOPMENT OF MULTIPLE SCLEROSIS
$0University Of Texas Hlth Sci Ctr Houston · M01 · FY2001 · RR
COPAXONE IN PATIENTS WITH MULTIPLE SCLEROSIS--OPEN LABEL STUDY
$0University Of Texas Hlth Sci Ctr Houston · M01 · FY2001 · RR
ORAL INTERFERON ALPHA--EFFECTS IN RELAPSING REMITTING MULTIPLE SCLEROSIS
$0University Of Texas Hlth Sci Ctr Houston · M01 · FY2001 · RR
Attenuating microglial-dependent axonal pathology in EAE
$0Jeffrey L. Dupree · Va Veterans Administration Hospital · I01 · FY2024 · VA
Investigating a Model for PM-Induced Exacerbation of Autoimmunity
$0Joshua D Mezrich · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2019 · VA
FUS Protein Homeostasis in ALS
$0Haining Zhu · Va Medical Center - Lexington, Ky · I01 · FY2019 · VA
AVONEX IN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
$0University Of Texas Hlth Sci Ctr Houston · M01 · FY2001 · RR
Immune Modulation and Cardiac Remodeling
$0Mary C Nakamura · Veterans Affairs Med Ctr San Francisco · I01 · FY2019 · VA
Efficacy, tolerability, &safety of glatiramer acetate in multiple sclerosis
$0University Of Texas Hlth Sci Ctr Houston · M01 · FY2001 · RR